Literature DB >> 11788998

Newly identified proteins in human nasal lavage fluid from non-smokers and smokers using two-dimensional gel electrophoresis and peptide mass fingerprinting.

Bijar Ghafouri1, Bengt Ståhlbom, Christer Tagesson, Mats Lindahl.   

Abstract

Human nasal lavage fluids (NLFs) were analyzed with two-dimensional gel electrophoresis (2-DE) and proteins were identified with peptide mass fingerprinting using matrix-assisted laser desoption/ionization time of flight mass spectrometry. In some cases, the identification was verified by analysis of post-source decay fragmentation spectra. Many of the identified proteins were new forms or fragments of previously found proteins (e.g. albumin, lactoferrin, cystatin, calgranulin, von Ebners gland protein and palate lung nasal epithelium clone), while others were proteins that have previously been indicated by 2-DE image matching or immunoblots (e.g. apolipoprotein AI, lysozyme C, and Clara cell secretory protein). Some new proteins, not shown before in 2-DE patterns of NLF were also found, e.g. mammaglobin B, (2)-microglobulin and immunoglobulin J chain. Of the identified NLF proteins many appear to be involved in inflammatory and immune responses. A study was therefore conducted to investigate if the levels of these proteins were changed in smokers compared to nonsmokers. It was found that NLF from smokers contained decreased levels of Clara cell secretory protein, and increased proportions of a truncated variant of lipocortin-1, three acidic forms of alpha(1)-antitrypsin, and one phosphorylated form of cystatin S. Furthermore, NLF from smokers contained increased proportions of a new variant of palate lung nasal epithelium clone (PLUNC), a recently identified airway irritation marker. The results demonstrate that 2-DE of NLF may be used to assess alterations of proteins or post-translationally modified proteins in smokers. Clara cell secretory protein (CC 16, CC 10) and lipocortin-1 are two anti-inflammatory, phospholipase A(2) inhibitory proteins, and alpha(1)-antitrypsin and cystatin S are two proteinase inhibitors. Changed levels of these proteins may therefore be of importance to the airway inflammation caused by smoking. The results also support the notion that PLUNC is involved in inflammatory responses in the upper airways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788998

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  31 in total

Review 1.  Proteomics for nasal secretion analysis.

Authors:  Begoña Casado
Journal:  Curr Allergy Asthma Rep       Date:  2004-05       Impact factor: 4.806

2.  Exploration of the normal human bronchoalveolar lavage fluid proteome.

Authors:  Jinzhi Chen; Soyoung Ryu; Sina A Gharib; David R Goodlett; Lynn M Schnapp
Journal:  Proteomics Clin Appl       Date:  2008-04       Impact factor: 3.494

3.  Airway irritation among indoor swimming pool personnel: trichloramine exposure, exhaled NO and protein profiling of nasal lavage fluids.

Authors:  Louise Fornander; Bijar Ghafouri; Mats Lindahl; Pål Graff
Journal:  Int Arch Occup Environ Health       Date:  2012-06-23       Impact factor: 3.015

Review 4.  Bactericidal/Permeability-increasing protein fold-containing family member A1 in airway host protection and respiratory disease.

Authors:  Clemente J Britto; Lauren Cohn
Journal:  Am J Respir Cell Mol Biol       Date:  2015-05       Impact factor: 6.914

5.  Extensive fractionation and identification of proteins within nasal lavage fluids from allergic rhinitis and asthmatic chronic rhinosinusitis patients.

Authors:  Linda M Benson; Christopher J Mason; Oren Friedman; Hirohito Kita; Harold Robert Bergen; Douglas A Plager
Journal:  J Sep Sci       Date:  2009-01       Impact factor: 3.645

6.  Lipids including cholesteryl linoleate and cholesteryl arachidonate contribute to the inherent antibacterial activity of human nasal fluid.

Authors:  Thai Q Do; Safiehkhatoon Moshkani; Patricia Castillo; Suda Anunta; Adelina Pogosyan; Annie Cheung; Beth Marbois; Kym F Faull; William Ernst; Su Ming Chiang; Gary Fujii; Catherine F Clarke; Krishna Foster; Edith Porter
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

7.  Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected].

Authors:  Michael Mitas; Loretta Hoover; Gerard Silvestri; Carolyn Reed; Mark Green; Andrew T Turrisi; Carol Sherman; Kaidi Mikhitarian; David J Cole; Mark I Block; William E Gillanders
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

8.  Comparison of proteomic and transcriptomic profiles in the bronchial airway epithelium of current and never smokers.

Authors:  Katrina Steiling; Aran Y Kadar; Agnes Bergerat; James Flanigon; Sriram Sridhar; Vishal Shah; Q Rushdy Ahmad; Jerome S Brody; Marc E Lenburg; Martin Steffen; Avrum Spira
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

9.  Assessment of smoking status based on cotinine levels in nasal lavage fluid.

Authors:  Mehmet Hakan Ozdener; Karen K Yee; Ryan McDermott; Beverly J Cowart; Aldona A Vainius; Pamela Dalton; Nancy E Rawson
Journal:  Tob Induc Dis       Date:  2009-07-03       Impact factor: 2.600

10.  PLUNC is a novel airway surfactant protein with anti-biofilm activity.

Authors:  Lokesh Gakhar; Jennifer A Bartlett; Jon Penterman; Dario Mizrachi; Pradeep K Singh; Rama K Mallampalli; S Ramaswamy; Paul B McCray
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.